Robert Busard Brown is CEO at Brickell Biotech, Inc. (BBI). They have made 1 open-market trade across 1 company since 2020, most recently 2021-03-15.
CIK 0001782344
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $118K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BBI | 186,957 | $439K |
Shares reported on the most recent Form 4, priced at the 2021-03-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BBI | BUY | 2021-03-15 | 2021-03-17 | $1.18 | $118K | -9.7% | -31.9% | -30.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.